● DelayedAs of Aug 13, 2026

Innovent Biologics, Inc.

HKG: 1801✓

HealthcareBiotechnologyHKSE

● DelayedAs of Aug 13, 2026

$12.12HK$95.15-0.42%

$21.11BMarket cap

151.19xP/E ratio

0Volume (24h)

HealthcareBiotechnologyHKSE

Price target & revenue forecast

Upgrade to Plus for the average price target, the upside write-up, and the analyst revenue forecast.

71% OFF~~$23.99~~ $6.99/mo

Ends in23:59:59

Cancel anytime. Secure checkout via Stripe.

Next earnings

Aug 26, 2026

Estimated report date

Analyst estimates are third-party opinions, not guarantees. For information only.